000186465 001__ 186465
000186465 005__ 20210129214910.0
000186465 0247_ $$2doi$$a10.1186/s13012-014-0196-7
000186465 0247_ $$2Handle$$a2128/8381
000186465 0247_ $$2WOS$$aWOS:000349184400001
000186465 0247_ $$2altmetric$$aaltmetric:3064151
000186465 0247_ $$2pmid$$apmid:25582164
000186465 037__ $$aFZJ-2015-00539
000186465 041__ $$aEnglish
000186465 082__ $$a610
000186465 1001_ $$0P:(DE-HGF)0$$aScholten, N.$$b0$$eCorresponding Author
000186465 245__ $$aWho does it first? The uptake of medical innovations in the performance of thrombolysis in ischemic stroke patients in Germany: A study based on hospital quality data
000186465 260__ $$aLondon$$bBioMed Central$$c2015
000186465 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1422887012_13708
000186465 3367_ $$2DataCite$$aOutput Types/Journal article
000186465 3367_ $$00$$2EndNote$$aJournal Article
000186465 3367_ $$2BibTeX$$aARTICLE
000186465 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000186465 3367_ $$2DRIVER$$aarticle
000186465 520__ $$aBackgroundSince 2000, systemic thrombolysis has been the only approved curative and causal treatment for acute ischemic stroke. In 2009, the guidelines of the German Society for Neurology were updated and the therapeutic window for performing thrombolysis was extended. The implementation of new therapies is influenced by many factors. We analyzed the factors at the organizational level that influence the implementation of thrombolysis in stroke patients.MethodsThe data published by the majority of German hospitals in their structured quality reports was assessed. We calculated a regression model in order to measure the influence of hospital/department-level characteristics (e.g., teaching status, ownership, location, and number of hospital beds) on the implementation of thrombolysis in 2006 (this is the earliest point in time that can be analyzed on this data basis). In order to measure the effect of the guideline update in 2009 on the thrombolysis rate (TR) change between 2008 and 2010, we performed a Wilcoxon signed-rank test and utilized a regression model.ResultsIn 2006, 61.5% of a total of 286 neurology departments performed systemic thrombolysis to treat ischemic strokes. The influencing factors for the use of systemic thrombolysis in 2006 were the existence of a stroke unit (+) and a hospital size of between 500 and 1,000 beds (−). A significant increase of the mean departmental TR (thrombolysis rate) from 6.7% to 9.2% between 2008 and 2010 was observed after the guideline update in 2009. For the departments performing thrombolysis in 2008 and 2010, our analysis could not show any additional influencing factors on a structural level that would explain the TR rise during the period 2008–2010.ConclusionsBecause ischemic stroke patients benefit from systemic thrombolysis, it is necessary to examine possible barriers at the organizational level that hinder the implementation. Our data shows that, organizational factors have an influence on the implementation of thrombolysis. However, the recent guideline update resulted in a TR rise that occurred at all hospitals, regardless of the measured structural conditions, as our analysis could not identify any structural factors that might have influenced the TR after the guideline update.
000186465 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000186465 7001_ $$0P:(DE-HGF)0$$aPfaff, H.$$b1
000186465 7001_ $$0P:(DE-HGF)0$$aLehmann, H. C.$$b2
000186465 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b3$$ufzj
000186465 7001_ $$0P:(DE-HGF)0$$aKarbach, U.$$b4
000186465 773__ $$0PERI:(DE-600)2225822-X$$a10.1186/s13012-014-0196-7$$p10$$tImplementation science$$v10$$x1748-5908$$y2015
000186465 8564_ $$uhttps://juser.fz-juelich.de/record/186465/files/FZJ-2015-00539.pdf$$yOpenAccess
000186465 8564_ $$uhttps://juser.fz-juelich.de/record/186465/files/FZJ-2015-00539.jpg?subformat=icon-144$$xicon-144$$yOpenAccess
000186465 8564_ $$uhttps://juser.fz-juelich.de/record/186465/files/FZJ-2015-00539.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000186465 8564_ $$uhttps://juser.fz-juelich.de/record/186465/files/FZJ-2015-00539.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000186465 909CO $$ooai:juser.fz-juelich.de:186465$$pdnbdelivery$$pVDB$$pdriver$$popen_access$$popenaire
000186465 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000186465 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aWoS$$bSocial Sciences Citation Index
000186465 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000186465 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000186465 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000186465 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000186465 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000186465 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000186465 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000186465 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000186465 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF <  5
000186465 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000186465 915__ $$0StatID:(DE-HGF)1020$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences
000186465 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000186465 9141_ $$y2015
000186465 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000186465 9130_ $$0G:(DE-HGF)POF2-333$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$aDE-HGF$$bGesundheit$$lFunktion und Dysfunktion des Nervensystems$$vPathophysiological Mechanisms of Neurological and Psychiatric Diseases$$x0
000186465 9130_ $$0G:(DE-HGF)POF2-89572$$1G:(DE-HGF)POF2-89570$$2G:(DE-HGF)POF3-890$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x1
000186465 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000186465 920__ $$lyes
000186465 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000186465 980__ $$ajournal
000186465 980__ $$aVDB
000186465 980__ $$aUNRESTRICTED
000186465 980__ $$aFullTexts
000186465 980__ $$aI:(DE-Juel1)INM-3-20090406
000186465 9801_ $$aFullTexts